OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT04691687

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
New York Presbyterian Brooklyn Methodist Hospital (from the registry)
Registry
  • NCT NCT04691687
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04691687. Randomized; quadruple masking; primary purpose treatment. Start 2012-05-01 (actual); primary completion 2017-12-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure
Acronym
OUTLAST
Condition
Heart Failure
Intervention (Drug)
Furosemide
Intervention (Drug)
IV Solution
Lead sponsor
New York Presbyterian Brooklyn Methodist Hospital (class: other)

Record details

Record id
cardio:ct-nct04691687
Content hash
14b73dc74916b15e0714aff061100ee37b626e1a5ac031a51bbb0a554f1995d9